A drug called regorafenib significantly improved progression-free survival in patients with metastatic osteosarcoma, according to a study published in the Journal of Clinical Oncology.
Browsing: Clinical Breakthroughs
Cholesterol levels in U.S. youth have improved from 1999 to 2016, but only half of children and adolescents are in the ideal range, according to a new study published in JAMA.
An artificial intelligence system was able to detect malignant lung cancer nodules on CT scans as well as — or better — than expert radiologists, according to a new study.
Waiting to begin treatments for diabetic macular edema until patients experience vision loss resulted in similar outcomes compared to starting treatments prior to vision loss, according to a recent study published in JAMA.
Death rates due to heart failure are now increasing, and this increase is most prominent among younger adults under 65, according to a new study.
In the Department of Radiology, collaboration is essential for translating discoveries from bench to bedside.
Visitor restrictions during winter months were associated with a significant decrease in the transmission of viral respiratory infections among hospitalized children, according to a Northwestern study.
A relatively newer and more complex therapy for diffuse large B-cell lymphoma did not show improvement over the current standard of care, but provides important new context for how the cancer affects treatment options.
A drug called niraparib showed clinically relevant activity in women with relapsed ovarian cancer who had exhausted all previous treatment options, according to a recent study.
High doses of vitamin D, in combination with chemotherapy, may improve progression-free survival in patients with advanced colorectal cancer, according to a clinical trial published in JAMA.